Annotation Detail for CPSF1
Basic Information
Top
Pathway ID | Pathway Name |
---|
| Post-Elongation Processing of the Transcript |
| Transcription |
| mRNA Processing |
| Gene Expression |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of CPSF1 mRNA | affects expression | 21346803
|
D008727 |
Methotrexate |
CPSF1 protein affects the susceptibility to Methotrexate | affects response to substance | 16217747
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of CPSF1 mRNA | decreases expression | 17426115
|
D012643 |
Selenium |
Selenium results in increased expression of CPSF1 mRNA | increases expression | 19244175
|
D014810 |
Vitamin E |
Vitamin E results in increased expression of CPSF1 mRNA | increases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
4.78 | 12039119 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.52 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
4.02 | 16434500 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
3.16 | 17286800 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.52 | 19483382 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
3.07 | 16978400 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
4.41 | 16050911 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
1.79 | 16705839 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
3.00 | 6135515 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.08 | 19176532 |
MESH:D003092 |
Colitis |
|
Selenium |
4.26 | 17936198 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
3.08 | 9562676 12039119 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
3.08 | 19769572 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.50 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.58 | 19747007 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.56 | 18249437 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.57 | 20191521 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
4.21 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
4.21 | 15131321 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
5.32 | 9068938 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.85 | 12083418 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
3.14 | 19236843 20131406 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.63 | 16518429 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
3.15 | 16080930 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
7.62 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Selenium |
7.62 | 17162251 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.48 | 16221962 19772884 19176532 18467677 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.80 | 16490937 16863852 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
4.58 | 14716179 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.53 | 20558911 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
13.09 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
13.09 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.85 | 16306350 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
2.98 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
4.26 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
3.28 | 16705839 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.51 | 9562676 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
3.87 | 14986274 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.46 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
2.46 | 16169303 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
4.77 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.77 | 15890375 20007298 16377806 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.74 | 6135515 2876784 2876786 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
3.40 | 16863852 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
5.63 | 18516814 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
1.90 | 11062179 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
4.19 | 17352296 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
2.97 | 15318939 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.90 | 15107826 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
5.82 | 17488658 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.99 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.26 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.22 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.40 | 18551238 7678174 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.09 | 17405874 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.88 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.78 | 16049721 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
5.50 | 15087411 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
3.25 | 15084515 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
3.53 | 17410198 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
5.20 | 17352296 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.53 | 19058328 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.76 | 18551238 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.51 | 18709164 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.81 | 16517955 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
5.47 | 9562676 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
2.40 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.86 | 10091137 |